Treatment of patients with respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs

Current Allergy and Asthma Reports

Volumn 4, Issue 2, 2004, Pages 139-143

  Simon, Ronald A ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 1; HYDROCORTISONE; LYSINE ACETYLSALICYLATE; MONTELUKAST; NONSTEROID ANTIINFLAMMATORY AGENT; OXYMETAZOLINE; PARACETAMOL; PREDNISONE; ROFECOXIB; TARTRAZINE; ZAFIRLUKAST; ZILEUTON;

ASTHMA; BRONCHOSPASM; CLINICAL FEATURE; CLINICAL TRIAL; CROSS REACTION; DESENSITIZATION; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; GASTRITIS; HUMAN; LARYNX SPASM; NOSE CONGESTION; NOSE POLYP; NOSE SECRETION; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; RHINOSINUSITIS;

EID: 3142735769     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-004-0059-4     Document Type: Review

References (35)

1. Stevenson D, Simon RA: Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. In Allergy: Principles and Practice, edn 6. Edited by Middleton E Jr, Ellis EF, Yunginger JW, et al. St. Louis: Mosby; 2003.
2. Berges-Gimeno MP, Simon RA, Stevenson DD: The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002, 89:474-478.
3. Settipane RA, Shrank PJ, Simon RA, et al.: Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol 1995, 96:480-485.
4. Stevenson DD, Hougham A, Schrank P, et al.: Disalcid cross-sensitivity in aspirin sensitive asthmatics. J Allergy Clin Immunol 1990, 86:749-758.
5. Stevenson DD, Simon RA, Lumry WR, et al.: Pulmonary reactions to tartrazine. Pediatr Allergy Immunol 1992, 3:222-227.
6. Feigenbaum BA, Stevenson DD, Simon RA: Lack of cross-sensitivity to IV hydrocortisone in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol 1995, 96:545-548.
7. Manning ME, Stevenson DD: Pseudoallergic drug reactions: aspirin, non-steroidal anti-inflammatory drugs, dyes, additives and preservatives. In Immunology and Allergy Clinics of North America, vol 11, edn 3. Edited by van Arsdel P Jr. Philadelphia: WB Saunders; 1991:659-678.
8. Woessner KM, Simon RA, Stevenson DD: Monosodium glutamate (MSG) sensitivity in asthma. J Allergy Clin Immunol 1999, 104:305-310.
9. Szczeklik A, Nizankowska E, Bochenek G, et al.: Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001, 31:219-222.
10. Stevenson D, Simon RA: Lack of cross-reactivity between rofecoxib and aspirin in aspirin sensitive asthmatic patients. J Allergy Clin Immunol 2001, 108:47-51.
11. Woessner KM, Simon RA, Stevenson DD: The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum 2002, 46:2201-2206.
12. Zeiss CR, Lockey RF: Refractory period to aspirin in a patient with aspirin-induced asthma. J Allergy Clin Immunol 1976, 57:440-448.
13. Pleskow WW, Stevenson DD, Mathison DA, et al.: Aspirin desensitization in aspirin sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol 1982, 69:11-19.
14. Widal MF, Abrami P, Lermeyez J: Anaphylaxie et idiosyncrasie. Presse Med 1922, 30:189-192.
15. Bianco S, Robuschi M, Petrigini G: Aspirin-induced tolerance in aspirin-asthma detected by a new challenge test. IRCS J Med Sci 1977, 5:129.
16. Stevenson DD, Simon RA, Mathison DA: Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 1980, 66:82-88.
17. Stevenson DD: Aspirin desensitization. N Engl Reg Allergy Proc 1986, 7:101-104.
18. Stevenson DD: Aspirin sensitivity: new approaches to detection and desensitization. Intern Med Spec 1987, 8:60-68.
19. Slavin RG: Asthma and sinusitis. J Allergy Clin Immunol 1992, 90:534-537.
20. Mastalerz L, Milewski M, Duplaga M, et al.: Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma. Allergy 1997, 52:895-900.
21. Mathison DA, Stevenson DD: Aspirin sensitivity in rhinosinusitis-asthma. In Current Therapy in Allergy, Immunology and Rheumatology. Edited by Lichtenstein LM, Fanci AS. St. Louis: Mosby; 1985:27-30.
22. Schaitkin B, May M, Shapiro A, et al.: Endoscopic sinus surgery: 4-year follow-up on the first 100 patients. Laryngoscope 1993, 103:1117-1120.
23. Kennedy DW: Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope 1992, 102:1-18.
24. McFadden EA, Woodson BT, Fink JN, et al.: Surgical treatment of aspirin triad sinusitis. Am J Rhinol 1997, 11:263-270.
25. Dahlen BN, Nizankowska E, Szczeklik A, et al.: Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 1998, 157:1187-1194.
26. Dahlen S, Malmstrom K, Nizankowska E, et al.: Improvement of aspirin-intolerant asthma by montelukast, a leukotriene anatagonist: a randomised, double blind, placebo controlled trial. Am J Respir Crit Care Med 2002, 165:9-14.
27. Sousa AR, Parikh A, Scadding G, et al.: Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002, 347:1493-1499.
28. Stevenson DD, Pleskow WW, Simon RA, et al.: Aspirin-sensitive rhinosinusitis asthma: a double-blind cross-over study of treatment with aspirin. J Allergy Clin Immunol 1984, 73:500-507.
29. Sweet JA, Stevenson DD, Simon RA, et al.: Long term effects of aspirin desensitization treatment for aspirin-sensitive rhinosinusitis asthma. J Allergy Clin Immunol 1990, 86:59-65.
30. Stevenson DD, Hankammer MA, Mathison DA, et al.: Long-term ASA desensitization-treatment of aspirin sensitive asthmatic patients: clinical outcome studies. J Allergy Clin Immunol 1996, 98:751-758.
31. Berges-Gimeno MP, Simon RA, Stevenson DD: Long-term desensitization with aspirin in aspirin-exacerbated respiratory disease (AERD). J Allergy Clin Immunol 2003, 111:180-186.
32. Berges-Gimeno MP, Simon RA, Stevenson DD: Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2003, 90:338-341.
33. Berges-Gimeno MP, Simon RA, Stevenson DD: The effect of leukotriene modifier drugs on aspirin-induced asthma and rhinitis. Clin Exp Allergy 2002, 32:1491-1496.
34. Patriarca G, Bellioni P, Nucera E, et al.: Intranasal treatment with lysine acetylsalcylate in patients with nasal polyposis. Ann Allergy 1991, 67:588-593.
35. Dahlen B: Treatment of aspirin-intolerant asthma with anti-leukotrienes. Am J Respir Crit Care Med 2000, 161:S137-S141.